TMSB4X and head and neck squamous cell carcinoma: Furthermore, knockdown of TMSB4X in HNSCC cell line, SAS, could reduce the cell proliferation (Fig. 5C), invasion ability in vitro (Fig. 5D) as well as lymph node metastasis in vivo (Fig. 5E).